Evaluation of the usefulness of Unkeito together with Boiogito for arthralgia in menopausal patients.

Evaluation of the usefulness of Unkeito together with Boiogito for arthralgia in menopausal patients. - Evaluation of the usefulness of Unkeito together with Boiogito for arthralgia in menopausal patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051156

Enrollment

Registered

2023-06-01

Start date

2023-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

menopausal arthralgia

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients who attended the Department of Kampo Medicine, Tokai University Hospital, and the Kampo outpatient clinics of the Tomai Atsugi Clinic and Joetsu General Hospital between April 2020 and October 2022, and were treated for menopausal arthralgia with Unkeito extract and Boiogito extract in combination.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Subjective intensity of the patient's arthralgia pain.	—

Secondary

Measure	Time frame
Adverse events caused by medication	—

Countries

Japan

Contacts

Public ContactTatsuyna Nogami

Tokai University Department of Kampo Medicine

t-nogami@tsc.u-tokai.ac.jp+81-463-93-1121

Outcome results